227 related articles for article (PubMed ID: 37522278)
1. Pathology steered stratification network for subtype identification in Alzheimer's disease.
Xu E; Zhang J; Li J; Song Q; Yang D; Wu G; Chen M
Med Phys; 2024 Feb; 51(2):1190-1202. PubMed ID: 37522278
[TBL] [Abstract][Full Text] [Related]
2. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
3. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
[TBL] [Abstract][Full Text] [Related]
4. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
Popuri K; Ma D; Wang L; Beg MF
Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of Alzheimer's dementia: neuroimaging contributions.
Ten Kate M; Ingala S; Schwarz AJ; Fox NC; Chételat G; van Berckel BNM; Ewers M; Foley C; Gispert JD; Hill D; Irizarry MC; Lammertsma AA; Molinuevo JL; Ritchie C; Scheltens P; Schmidt ME; Visser PJ; Waldman A; Wardlaw J; Haller S; Barkhof F
Alzheimers Res Ther; 2018 Oct; 10(1):112. PubMed ID: 30376881
[TBL] [Abstract][Full Text] [Related]
6. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
7. Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
Yan T; Wang Y; Weng Z; Du W; Liu T; Chen D; Li X; Wu J; Han Y
J Alzheimers Dis; 2019; 68(3):1013-1027. PubMed ID: 30958352
[TBL] [Abstract][Full Text] [Related]
8. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
[TBL] [Abstract][Full Text] [Related]
9. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
10. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
[TBL] [Abstract][Full Text] [Related]
11. Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
Khan AF; Adewale Q; Baumeister TR; Carbonell F; Zilles K; Palomero-Gallagher N; Iturria-Medina Y;
Brain; 2022 Jun; 145(5):1785-1804. PubMed ID: 34605898
[TBL] [Abstract][Full Text] [Related]
12. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
[TBL] [Abstract][Full Text] [Related]
13. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.
Cavedo E; Lista S; Khachaturian Z; Aisen P; Amouyel P; Herholz K; Jack CR; Sperling R; Cummings J; Blennow K; O'Bryant S; Frisoni GB; Khachaturian A; Kivipelto M; Klunk W; Broich K; Andrieu S; de Schotten MT; Mangin JF; Lammertsma AA; Johnson K; Teipel S; Drzezga A; Bokde A; Colliot O; Bakardjian H; Zetterberg H; Dubois B; Vellas B; Schneider LS; Hampel H
J Prev Alzheimers Dis; 2014 Dec; 1(3):181-202. PubMed ID: 26478889
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
[TBL] [Abstract][Full Text] [Related]
15. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
16. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
[TBL] [Abstract][Full Text] [Related]
17. Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network.
Zheng C; Zhao W; Yang Z; Tang D; Feng M; Guo S;
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110873. PubMed ID: 37827426
[TBL] [Abstract][Full Text] [Related]
18. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
Abdelaziz M; Wang T; Elazab A
J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer's disease: deep learning analysis in 3238 participants worldwide.
Zhang Y; Li H; Zheng Q
Eur Radiol; 2023 Aug; 33(8):5385-5397. PubMed ID: 36892643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
